In a dynamic and often unpredictable economic landscape, the latest roundup of U.S. startup funding rounds reveals a cautious yet strategic investment climate. While the overall size of the largest deals this week appears somewhat smaller than the blockbuster figures seen in previous periods, a clear pattern emerges: investors are doubling down on sectors that offer resilience and critical infrastructure in an increasingly complex world. Cybersecurity, consumer privacy, and artificial intelligence, alongside vital areas like biotech, healthcare, and robotics, have firmly established themselves as top priorities for venture capital, signaling a strategic shift towards foundational technologies and robust defense mechanisms against burgeoning threats.

The current investment sentiment reflects broader global uncertainties. Geopolitical tensions, persistent inflationary pressures, and the specter of economic slowdowns have cultivated an environment where investors are scrutinizing deals with greater diligence, prioritizing demonstrable value, clear market fit, and sustainable growth trajectories over speculative hyper-growth. This "flight to quality" has channeled significant capital into companies addressing fundamental needs, particularly those related to data protection, digital safety, and technological advancement. This week’s tally of top funding rounds, particularly those featuring cybersecurity and privacy-focused startups, underscores this interpretation, suggesting that in insecure times, security truly looks like an appealing sector for investment.

The week’s most substantial financing round, a $375 million Series B for consumer privacy and security platform Cloaked, exemplifies this trend. Other notable areas attracting significant capital injections include AI infrastructure, crucial for powering the next generation of intelligent systems; biotech, consistently addressing critical health challenges; healthcare technology, poised for transformative innovation; and robotics, which promises to redefine industrial efficiency and labor dynamics. These sectors represent not just promising ventures but strategic imperatives for the future economy.

Here’s a deeper dive into the week’s largest announced funding rounds for U.S.-based companies:

  1. Cloaked, $375M, Privacy: Leading the pack this week is Cloaked, a Massachusetts-based provider of consumer privacy and security tools, which successfully secured an impressive $375 million in Series B funding. The round was co-led by prominent venture capital firms General Catalyst and Liberty City Ventures, underscoring strong investor confidence in the burgeoning market for individual digital protection. Founded in 2020, Cloaked has rapidly carved out a niche by offering monthly subscriptions for individuals and families, providing essential tools to manage and protect personal data online. In an era where data breaches are commonplace and digital footprints are ever-expanding, platforms like Cloaked empower consumers with greater control over their privacy, making their offering increasingly vital. The substantial investment highlights a growing recognition that privacy is not just an enterprise concern but a fundamental consumer right and a significant market opportunity.

  2. Frore Systems, $143M, AI Infrastructure: In a testament to the critical need for advanced hardware to support the AI revolution, Frore Systems announced the close of $143 million in Series D funding. MVP Ventures led this significant financing round, which valued the 8-year-old, San Jose-based company at a remarkable $1.64 billion. Frore Systems specializes in developing integrated cooling architecture for high-performance AI computing and networking hardware. As AI models grow more complex and demanding, the energy consumption and heat generation of the underlying processors become immense challenges. Efficient cooling solutions are no longer just an optimization but a fundamental requirement for scaling AI infrastructure. Frore Systems’ innovative approach to thermal management is therefore seen as a key enabler for the continued advancement and widespread deployment of AI technologies, making it a strategic investment in the foundational layers of the AI future.

  3. (tied) XBow, $120M, Cybersecurity: Cybersecurity continues its strong showing with Seattle-based XBow, a provider of autonomous security testing technology, picking up $120 million in Series C funding. This round was jointly led by DFJ Growth and Northzone, validating the 2-year-old company’s innovative approach and pushing its valuation past the $1 billion mark, achieving unicorn status. XBow’s focus on autonomous security testing addresses a critical pain point for enterprises: the ever-increasing sophistication and volume of cyber threats necessitate proactive, automated defense mechanisms. Traditional manual testing methods are often slow and insufficient against rapidly evolving attack vectors. By leveraging automation and potentially AI-driven insights, XBow empowers organizations to identify and mitigate vulnerabilities more efficiently and continuously, bolstering their digital resilience in a hostile online environment.

  4. (tied) Oasis Security, $120M, Cybersecurity: Also securing $120 million, Oasis Security, a developer of identity security tools with a specific emphasis on AI agents, garnered significant backing from a consortium of top-tier VCs including Craft Ventures, Cyberstarts, Sequoia Capital, and Accel. This strong investor lineup underscores the perceived urgency and strategic importance of Oasis Security’s mission. Headquartered in New York with a significant presence in Israel, the 4-year-old company has now raised $195 million to date, according to Crunchbase data. The emergence of AI agents introduces new paradigms for identity and access management. As AI systems gain more autonomy and interact with sensitive data and systems, securing their identities and controlling their access becomes paramount. Oasis Security is at the forefront of this emerging challenge, developing tools to ensure that these powerful AI entities operate securely and within defined parameters, preventing new forms of digital compromise.

  5. (tied) Imperative Care, $100M, Medical Devices: The healthcare sector continues to attract substantial investment, as evidenced by Imperative Care’s $100 million in convertible note financing. Based in Campbell, California, Imperative Care is a medical device company dedicated to developing advanced treatments for stroke and various vascular diseases caused by blood clot formation. Elevage Medical Technologies and Perceptive Advisors led this investment, highlighting the ongoing demand for innovative solutions in critical care. Stroke remains a leading cause of disability and mortality worldwide, and timely, effective intervention is crucial. Imperative Care’s focus on groundbreaking medical devices for these conditions promises to improve patient outcomes, reduce long-term complications, and potentially save lives, representing a high-impact investment in human health.

  6. (tied) Bluesky, $100M, Social Media: In a somewhat retrospective disclosure, Seattle-based social network Bluesky announced this week that it had raised a previously unannounced $100 million Series B round, which actually closed last spring. The round was led by Bain Capital Crypto, signaling significant interest in decentralized social media platforms. Bluesky, an initiative originally spun out of Twitter (now X), aims to build an open and decentralized social protocol, offering an alternative to traditional, centrally controlled platforms. This investment from a crypto-focused fund underscores the growing belief in Web3 principles and the potential for new social media paradigms that offer greater user control, data portability, and censorship resistance. The late disclosure might reflect a strategic decision to build out its ecosystem before publicly announcing such a substantial capital injection, reinforcing its long-term vision.

  7. (tied) Cape, $100M, Privacy and Security: Reinforcing the privacy theme, Cape, a recently launched privacy-focused mobile network, secured $100 million in Series C funding. Bain Capital Ventures and IVP co-led the financing, which set a $900 million valuation for the Arlington, Virginia-based company. Cape’s entry into the market as a privacy-first mobile network addresses a critical consumer demand for telecommunications services that prioritize user data protection and anonymity. In an age of pervasive data collection and surveillance, offering a mobile network explicitly designed with privacy at its core represents a bold and timely proposition. This substantial investment indicates a strong market belief that consumers are willing to pay a premium for enhanced digital privacy and that a dedicated, secure mobile ecosystem could disrupt the traditional telecom landscape.

  8. Latent, $80M, Healthcare AI: The intersection of healthcare and artificial intelligence continues to be a hotbed of innovation. Latent, a San Francisco-based AI platform, picked up $80 million in a Series A round. Spark Capital and Transformation Capital led this financing, recognizing Latent’s potential to revolutionize patient care. Latent’s platform is specifically aimed at streamlining the crucial transition from clinical decision to therapy, an area often fraught with inefficiencies and delays. By leveraging AI, Latent can potentially optimize treatment pathways, personalize care plans, and ensure that patients receive the most appropriate and timely interventions. This focus on practical, actionable AI applications in healthcare demonstrates a shift towards solutions that deliver tangible improvements in patient outcomes and operational efficiency within complex medical systems.

  9. Crossbow Therapeutics, $77M, Biotech: In the dynamic field of oncology, Cambridge, Massachusetts-based Crossbow Therapeutics raised $77 million in Series B funding. Taiho Ventures and Arkin Bio Ventures led the round for this biotech startup, which is focused on developing novel antibody therapies to treat a broad range of cancers. The investment will specifically support a Phase 1 clinical trial of the company’s lead program, a critical milestone in drug development. Crossbow Therapeutics’ innovative approach to antibody therapies holds the promise of more targeted and effective cancer treatments, potentially reducing side effects and improving efficacy compared to conventional methods. This significant capital infusion underscores the continued investor appetite for groundbreaking biotechnological solutions that tackle some of humanity’s most challenging diseases.

  10. RoboForce, $52M, Robotics: Rounding out the top 10, RoboForce, a Milpitas, California-based startup, announced it picked up $52 million in fresh funding, bringing its total raise to $67 million. YZi Labs led this financing for a company focused on developing AI-enabled robot labor for industrial environments. As industries grapple with labor shortages, efficiency demands, and the need for greater automation, RoboForce’s solutions offer a compelling answer. Their AI-enabled robots are designed to perform complex tasks in manufacturing, logistics, and other industrial settings, promising increased productivity, reduced operational costs, and enhanced safety. This investment highlights the ongoing maturation of the robotics sector, moving beyond experimental applications to practical, scalable solutions that are transforming the backbone of global industries.

Methodology

This analysis tracked the largest announced funding rounds in the Crunchbase database that were raised by U.S.-based companies for the period of March 14-20, 2025. While Crunchbase strives for comprehensive coverage of venture capital activity, it’s important to note that a small time lag may occur as some rounds are reported late in the week or publicly disclosed retrospectively. The data presented offers a snapshot of the most significant investment trends and activities during this specific timeframe, reflecting the dynamic nature of startup financing.

The overarching narrative of this week’s funding rounds is one of strategic caution mixed with targeted aggression. Investors, while perhaps writing fewer mega-checks, are clearly identifying and backing companies that address critical, enduring needs in security, privacy, and the foundational technologies of AI and robotics. The continued strength in biotech and healthcare further solidifies the market’s commitment to innovation that delivers tangible, life-changing impact. As the investment landscape evolves, the focus on resilient, high-impact sectors like these will likely continue to define venture capital activity for the foreseeable future, driving innovation where it’s most needed.